TSXV:CLAS.H - Post by User
Post by
IamFlooredon Apr 17, 2020 11:36am
216 Views
Post# 30921998
Why did this deal fall through?
Why did this deal fall through?Just asking someone out there who is knowledgeable with the inside management team at KLY. I read that David Basso appeared to be involved with several biotech start up companies and was a major shareholder in many of them. On March 5, 2020 media release, Kalytera was to aquire Stero Biotech. Additional information talked about closing conditions involving a 100:1 share consolidation and a 10 million dollar private placement. I also read a source that Mr. Basso appeared to be the CEO of Stero Biotech. And on the closing of the deal, he would become the CEO and Chairman of Kalytera. And, he would be replacing the current board of directors. IF this is all true, is there no conflict of interest here or violation of any securites regulations. Just wondering? Intelligent answers only please?